CervoMed
CRVO
12 hedge funds and large institutions have $1.39M invested in CervoMed in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
25% less capital invested
Capital invested by funds: $1.86M → $1.39M (-$463K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$143K |
| 2 |
Renaissance Technologies
New York
|
+$21.1K |
| 3 |
VF
Virtu Financial
New York
|
+$11.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.1K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$4.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$66K |
| 2 |
Goldman Sachs
New York
|
-$37K |
| 3 |
WTC
WhitTier Trust Company
Reno,
Nevada
|
-$13K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$3.24K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2K |
CRVO Hedge Fund Activity: Q4 2017 in Review
12 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2017, worth a combined $1.39M — down 25% from $1.86M a quarter earlier.
Fund positioning in CRVO was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $143K. The largest seller was Millennium Management, exiting entirely with an estimated $66K sold.
- 12 institutional investors held CervoMed (CRVO) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $1.39M of CervoMed stock for Q4 2017, down 25% quarter-over-quarter.
- 3 funds opened new CervoMed positions in Q4 2017 and 3 closed out, a net change of 0 holders.
- The largest CervoMed buyer in Q4 2017 was Vanguard Group, an estimated $143K added.
- The largest CervoMed seller in Q4 2017 was Millennium Management, an estimated $66K sold.
Based on aggregated 13F filings for Q4 2017.